Cardiac MRI: A Patient's Guide to What It Is, How to Prepare, and How to Read the Report

If your cardiologist has scheduled you for a cardiac MRI, there’s a specific question your echo couldn’t answer. This guide covers what the test is, what happens on the day, and how to read the report when it comes back.

What Cardiac MRI Is and How It Differs From an Echo

Cardiac magnetic resonance imaging (cardiac MRI, or CMR) uses a strong magnet and radio waves to make detailed pictures of your heart. The magnetic field aligns the water molecules in your body, radio wave pulses knock them out of alignment, and as they spring back they give off tiny signals the scanner builds into images. No radiation is involved, which is a real advantage over CT and nuclear imaging for younger patients and for anyone who needs the same scan repeated over decades.

A plain MRI of the chest would just blur, because the heart never stops moving. Cardiac MRI freezes the motion three ways. ECG gating uses electrodes on your chest so the scanner triggers each image at the same point in the heartbeat, usually end-diastole when the heart is most relaxed and full. Breath-holds of 10 to 20 seconds remove the blurring from breathing. And specialized sequences, different combinations of radio pulses and timing, each highlight something different: the walls in motion, scar tissue, inflammation, iron, blood flow.

An echocardiogram is an ultrasound and it’s the workhorse of cardiology. It answers how the heart is pumping, whether the valves work, whether the chambers are normal size, whether there’s fluid around the heart. Cardiac MRI does all of that and then tells us what the muscle is made of. Where there’s scar, from an old heart attack or a healed inflammation or infiltrative disease. Where there’s active swelling, meaning current inflammation rather than old damage. Whether there’s iron overload from hemochromatosis or repeated transfusions. Whether amyloid protein has infiltrated the muscle. And whether the scar sits in a pattern that names a specific disease. Echo comes first. Cardiac MRI is what we add when the echo question isn’t fully answered.

Why Your Cardiologist Ordered It

The most common reason I order one is reduced pumping (a low ejection fraction, the percentage of blood pushed out with each beat) when we don’t yet know why. The possibilities are a long list: a prior heart attack, sometimes silent; dilated cardiomyopathy, genetic or not; cardiac amyloidosis; cardiac sarcoidosis; hemochromatosis; inflammatory cardiomyopathy from prior myocarditis; toxic cardiomyopathy from alcohol or chemotherapy; and tachycardia-mediated cardiomyopathy from a sustained fast rhythm. Treatment differs meaningfully for each one, and the scar pattern on MRI usually points straight at the answer.

Myocarditis, inflammation of the heart muscle usually from a virus and sometimes after a vaccine, classically shows up as chest pain with elevated cardiac enzymes (troponin) and clean coronary arteries on CT angiogram. Cardiac MRI is the diagnostic test of choice, showing both the swelling of active inflammation and the patchy scar that forms as it heals. The Lake Louise criteria combine those MRI findings with the clinical picture.

Amyloidosis is a slow buildup of misfolded protein in the muscle, in two main types, ATTR (hereditary or age-related) and AL (from a plasma cell disorder). Both produce a thickened, stiff heart that gets mislabeled as hypertensive heart disease or HCM for years. The clues that should trigger a workup are low EKG voltage in a patient whose echo shows thickened walls, both atria enlarged, restrictive filling on echo, carpal tunnel syndrome in both hands, and slow unexplained weight loss. MRI shows a characteristic diffuse sub-surface late gadolinium pattern that ignores coronary artery boundaries, plus elevated T1 mapping values.

Cardiac sarcoidosis forms granulomas in the heart muscle, hits younger and middle-aged adults, and can present as new heart block, dangerous ventricular arrhythmias, or unexplained reduced pumping. MRI shows patchy mid-wall and outer-wall scar, often in the basal interventricular septum, the upper part of the wall between the ventricles.

Hypertrophic cardiomyopathy is a genetic disease thickening the muscle in a specific pattern, often that same upper septum, sometimes obstructing outflow. MRI measures wall thickness more accurately than echo and shows how much scar is present, which predicts arrhythmia risk and informs whether to implant a defibrillator. Arrhythmogenic right ventricular cardiomyopathy is a genetic disease of the right ventricle (the chamber pumping blood to the lungs) causing fatty infiltration that predisposes to ventricular arrhythmias and sudden cardiac death in younger patients and athletes, and MRI catches the right ventricular changes echo often misses. Adults with repaired congenital heart disease (tetralogy of Fallot, atrial septal defect, ventricular septal defect, transposition of the great arteries) need imaging for decades, and MRI is preferred because it measures right ventricular size and function accurately, quantifies leaking valves, and uses no radiation across 30 or 40 studies in a lifetime.

Iron overload from hereditary hemochromatosis or repeated transfusions in sickle cell disease, thalassemia, or certain chemotherapy regimens gets measured directly with a sequence called T2 star. A T2* below 20 milliseconds means substantial iron overload. Below 10 milliseconds means severe overload needing urgent iron chelation.

How It Compares to Other Heart Tests

Echo is real-time ultrasound, no radiation, inexpensive, everywhere, and it covers chamber sizes, pumping strength, valve function, and basic structure. It doesn’t do tissue characterization or fine wall detail. Cardiac CT angiography (CCTA) is X-ray-based with IV contrast and is the best non-invasive look at the coronary arteries themselves, which makes it the test for ruling blocked arteries in or out as a cause of chest pain or new cardiomyopathy; it uses ionizing radiation, less on modern scanners but still meaningful. A coronary artery calcium score is a different CT that quantifies calcium in the coronaries for risk stratification in people without known heart disease, covered in my CAC score guide. A nuclear stress test (SPECT or PET) injects a radioactive tracer that tracks blood flow, comparing rest to stress to find where the coronaries aren’t delivering enough; it uses radiation and gives less tissue detail than MRI.

Cardiac MRI is the tissue characterization tool, best when the question is what the muscle is made of or why the heart is failing. It costs more, takes longer, and gets limited by claustrophobia, certain implants, severe kidney disease, and very irregular rhythms. A full workup for unexplained cardiomyopathy often runs all three: echo to confirm and measure, CCTA or coronary angiogram to rule out blocked arteries, then MRI to characterize the muscle.

The Sequences and What Each Shows

Cine sequences capture the heart in motion and give the structural foundation of the study: ejection fraction (more accurately than echo in many patients), regional wall motion, chamber sizes, valve function, and wall thickness.

Late gadolinium enhancement is usually the single most valuable sequence in the study. About 10 to 15 minutes after the contrast goes in, the radiologist takes pictures looking for where gadolinium lingered. Healthy muscle clears it fast; scarred or fibrotic muscle holds onto it and lights up bright against dark normal muscle. The pattern is what names the disease. Subendocardial scar following a coronary artery distribution means a prior heart attack in that territory. Mid-wall patchy scar in the upper septum suggests cardiac sarcoidosis. Diffuse sub-surface enhancement ignoring coronary boundaries suggests amyloidosis. Patchy outer-wall scar in a younger patient with chest pain and elevated troponin suggests myocarditis. Asymmetric upper septal thickening with mid-wall scar suggests hypertrophic cardiomyopathy.

T1 and T2 mapping measure magnetic properties of the tissue and help when the scar pattern is subtle. Native T1, done without contrast, detects diffuse fibrosis and infiltrative disease; elevated native T1 suggests amyloidosis, while low native T1 suggests iron overload or Anderson-Fabry disease. Post-contrast T1 with extracellular volume (ECV) calculation quantifies how much of the muscle volume is collagen scar, useful for diffuse fibrosis that never forms discrete bright spots. T2 mapping detects edema, the marker of active inflammation, and runs high in myocarditis and acute muscle injury. T2 star is the dedicated iron sequence, with values below 20 milliseconds meaning substantial overload and below 10 milliseconds meaning severe overload requiring urgent chelation.

Stress perfusion CMR uses a vasodilator drug (regadenoson, adenosine, or dipyridamole) to mimic exercise demand, and muscle fed by narrowed arteries shows contrast arriving late. It’s highly sensitive for ischemia with no radiation, and where it’s offered it’s an excellent alternative to nuclear stress testing. Phase-contrast and 4D flow sequences measure blood flow through valves and vessels, quantifying a leaking valve or the shunt fraction across a septal defect.

Preparing for Your Scan

You’ll get a safety screening questionnaire when you schedule or when you arrive. It asks about metal implants (pacemakers, defibrillators, joint replacements, surgical clips, cochlear implants, insulin pumps), any history of metal in your eye from metalwork or welding, tattoos, pregnancy, allergies and prior contrast reactions, kidney function, claustrophobia, and whether you can lie flat for an hour. Answer it completely. If you’re unsure whether an implant is MRI-safe, call your surgeon’s office or your cardiologist before the scan. The screening team would far rather field a question than discover an implant mid-scan.

For most cardiac MRIs you can eat, drink, and take your medications normally. Three exceptions. A stress perfusion study needs caffeine held for 12 to 24 hours beforehand, meaning no coffee, tea, chocolate, energy drinks, or caffeinated medications, because caffeine blocks the vasodilator. Some centers ask you to skip food for 2 to 4 hours if you’re getting contrast, to reduce the small risk of nausea. And patients on metformin are sometimes asked to hold it for 48 hours after contrast, an older recommendation that modern guidelines usually consider unnecessary, so ask your center for their policy.

If you have a pacemaker or ICD, a resynchronization device, or any other implanted cardiac device, confirm with your electrophysiologist that it’s MRI-conditional. Most implanted in the last 10 to 15 years are; older ones may not be. The device gets reprogrammed before the scan, a device technician monitors throughout, and it’s reprogrammed back afterward. That adds maybe 30 to 60 minutes to your visit and is routine anywhere that does cardiac MRI regularly.

Wear clothes with no metal, meaning no zippers, metal buttons, underwire bras, or metallic thread, though most centers hand you a gown anyway. Leave jewelry at home and bring cases for glasses and hearing aids. Bring your insurance card, the order, a medication list, and any prior cardiac imaging on disc for comparison. You can drive yourself both ways, since no sedation is used for a routine cardiac MRI.

What the Scan Is Actually Like

You’ll check in, review the safety form, and have an IV placed for the contrast, which feels like a blood draw. If you have hard veins, say so up front.

The scanner is a tunnel open at both ends, well lit, with a fan running. Wide-bore scanners have a 70 cm opening and are much more comfortable than the traditional 60 cm. Most centers in San Diego and Encinitas have wide-bore, worth asking about in advance if you’re claustrophobic. You lie on your back while the technologist places ECG electrodes for the gating, positions a saddle-shaped chest coil over your torso, and gives you earplugs and headphones, since the scanner is loud. You get a squeeze ball to press if you need to stop. The technologist can see and hear you throughout and talks to you between each set of pictures.

For the pictures that count, a voice says “breathe in, breathe out, breathe in, hold your breath,” and you hold 10 to 20 seconds. There will be 10 to 20 of these across the 45 to 60 minutes. Take a moderate breath rather than a maximum one, since holding a half-full chest is far easier, and stay still, because small movements blur the image. If you can’t make the full 20 seconds, hold what you can and breathe. The technologist will usually re-take it.

About 20 to 30 minutes in, the gadolinium goes through your IV. Most patients feel nothing; a few notice a cool sensation in the arm or a brief metallic taste. Modern macrocyclic gadolinium agents carry very low risk with normal or mildly reduced kidney function, and the risk of nephrogenic systemic fibrosis (the serious skin and organ disease caused by older agents in severe kidney disease) is close to zero with them. Allergic reactions happen but are rare. The contrast clears through your kidneys over a day or two. If your estimated GFR is below 30 or you’re on dialysis, the decision about contrast is individualized and the study is sometimes done without it.

Afterward everything comes off and you’re out in 5 to 10 minutes, free to eat, drink, drive, and resume normal activity with no restrictions. The radiologist typically finalizes the report within 24 to 72 hours, same day at high-volume academic centers and 2 to 5 days at smaller community ones. I call my patients with results within a week, sooner if anything urgent turns up. If you haven’t heard within 7 to 10 days, call the office.

Getting and Reading Your Report

The report lists the structural numbers first. Left ventricular end-diastolic volume, how much blood the ventricle holds when full. End-systolic volume, how much is left after it pumps. Ejection fraction, the percentage pumped out, where 55 percent or higher is normal. Left ventricular mass normalized to your body size. The same volumes and ejection fraction for the right ventricle. And wall thickness in millimeters at specific locations. If you have valve disease it quantifies regurgitation severity, stenosis severity, and specific measures like vena contracta width or regurgitant fraction. Related reading covers aortic stenosis, mitral regurgitation, and aortic regurgitation.

The late gadolinium enhancement section is the one to read closely. It says whether enhancement is present at all, the location, the distribution (subendocardial, mid-wall, subepicardial, or transmural), the pattern (focal, patchy, diffuse, coronary territory, non-coronary), and the percentage of left ventricular mass involved if it’s substantial. If mapping was done, you’ll see native T1 in milliseconds with the scanner’s reference range, post-contrast T1 and extracellular volume (ECV), T2 for edema, and T2* for iron with anything below 20 ms flagged.

The impression at the end is the radiologist’s read of what it all means. Common conclusions are findings consistent with prior myocardial infarction in a named coronary distribution, with cardiac amyloidosis, with active myocarditis and Lake Louise criteria met, with cardiac sarcoidosis, with hypertrophic cardiomyopathy at low, moderate, or high scar burden, or simply non-specific findings with clinical correlation recommended, or a normal study. The report also flags incidental findings outside the heart such as a small pericardial effusion, mediastinal lymphadenopathy, lung findings, or pleural effusion. Those usually aren’t why the study was ordered, but they still need follow-up.

What the Results Mean for Treatment

Subendocardial enhancement in a coronary distribution means you’ve had a heart attack in that territory, sometimes without knowing it. That calls for aggressive secondary prevention with high-intensity statin therapy, blood pressure control below 130/80, and antiplatelet therapy, plus further ischemia evaluation if you have ongoing chest pain or the coronary anatomy hasn’t been worked up, and a cardiac rehabilitation referral.

Mid-wall or outer-wall scar with no coronary territory points to non-ischemic cardiomyopathy, and the subtype drives management. Patients with substantial scar in non-ischemic cardiomyopathy face higher ventricular arrhythmia risk and may meet criteria for a defibrillator at lower thresholds than would otherwise apply.

No late gadolinium enhancement at all, in a patient with reduced pumping, is relatively good news. The prognosis is more favorable than for similar patients with extensive scar, and the absence of fibrosis makes reversible causes more likely, including tachycardia-mediated cardiomyopathy, healing myocarditis, alcohol-related cardiomyopathy, and peripartum cardiomyopathy. Recovery of pumping function on optimal medical therapy is more likely in this group.

The real payoff is when the scan names a disease with its own treatment. ATTR cardiac amyloidosis can be treated with tafamidis, a TTR stabilizer, or with newer TTR-silencer drugs that have transformed the prognosis. AL amyloidosis is treated with daratumumab-based or bortezomib-based regimens alongside hematology. Cardiac sarcoidosis is treated with prednisone and steroid-sparing agents plus a defibrillator-capable device when indicated. Hemochromatosis is treated with therapeutic phlebotomy or iron chelation. And hypertrophic cardiomyopathy with high scar burden tips the decision toward a defibrillator and toward mavacamten. A patient carried for years under “non-ischemic cardiomyopathy of unclear cause” can have their whole trajectory changed by the scan that finally names the disease.

Contraindications and Special Situations

The old rule that any pacemaker or ICD ruled out an MRI is gone. Most devices from the last 10 to 15 years are MRI-conditional, with safe scanning requiring interrogation and reprogramming beforehand, continuous monitoring by a device technician, reprogramming back afterward, and scanning at a field strength the device is rated for, usually 1.5 Tesla and sometimes 3 Tesla. Older non-conditional devices can occasionally still be imaged at experienced centers with case-by-case evaluation.

For claustrophobia, a wide-bore scanner at 70 cm instead of 60 cm handles most cases. Oral lorazepam before the appointment helps many patients, though you’ll need a ride home if you take it. Open MRI scanners have no enclosing tunnel but lower image quality, sometimes too low for a full cardiac study. General anesthesia is reserved for patients who can’t tolerate the scan any other way and genuinely need the information. Mention any claustrophobia when you schedule.

In severe chronic kidney disease with an estimated GFR below 30, older gadolinium agents carried a nephrogenic systemic fibrosis risk. Modern macrocyclic agents such as gadoteridol and gadoterate meglumine carry much lower risk and are considered safe in mild to moderate kidney disease. In severe disease or on dialysis the decision is individualized, sometimes scanning without contrast, which loses the late gadolinium information but preserves everything else.

Atrial fibrillation degrades image quality because ECG gating depends on a predictable rhythm. Modern scanners handle it better than older ones, but very irregular AF still produces suboptimal images. Rate control with a beta blocker or calcium channel blocker before the scan helps, and if your AF is intermittent, scheduling for a day you’re in sinus rhythm is ideal.

MRI without gadolinium is generally considered safe in pregnancy and is often the preferred cardiac test when one is needed, with echo usually tried first. Gadolinium crosses the placenta and is avoided in pregnancy unless truly necessary.

Most metal implants are fine, including modern joint replacements, coronary stents, dental fillings and crowns, surgical clips and staples, heart valves implanted in the last 30 years, and most modern IUDs. The ones to always check individually are older aneurysm clips in the brain, older cochlear implants, some neurostimulators, metal shrapnel or bullet fragments near critical structures, and some insulin pumps, though many newer pumps are MRI-conditional. When in doubt the imaging center will research the specific device and clear it beforehand.

Limitations, Cost, and Insurance

Image quality depends on breath-hold ability, since patients who can’t hold 10 to 20 seconds get lower-quality images, though free-breathing techniques help; on heart rhythm, since atrial fibrillation and frequent ectopic beats both degrade gating; on body habitus, since very large patients sometimes hit technical limits; and on the scanner, since a 3-Tesla machine generally outperforms a 1.5-Tesla one, while wide-bore and traditional bore give equivalent quality at the same field strength.

There are things MRI simply doesn’t do. It detects prior heart attack scar and ischemia through stress perfusion, but it isn’t the test for direct coronary anatomy; that’s CT coronary angiography or invasive angiography. It doesn’t show calcium directly, so calcium scoring stays with the CAC score guide. And in the first hours of a heart attack the findings are still evolving, so the cath lab and echo are better in that acute window. Reading cardiac MRI is also its own subspecialty, and not every radiologist who reads a brain MRI reads a cardiac one well, so I prefer centers with dedicated cardiac imaging radiologists or imaging cardiologists.

Cash prices run about $1,500 to $3,500 depending on the center and whether stress perfusion is included, driven by a scanner costing millions, a 45 to 60 minute scan against 5 to 30 minutes for other tests, the specialized expertise to perform and interpret it, and the contrast. Medicare covers cardiac MRI for most indications with a clear medical need, including suspected cardiomyopathy, myocarditis, infiltrative disease, HCM characterization, and congenital follow-up, and most commercial plans follow similar rules. Prior authorization is sometimes required and adds a few days. On a high-deductible plan, ask for the self-pay rate too, often $1,500 to $2,500, which can beat the billed insurance rate if you haven’t met your deductible.

Common Questions

Is the gadolinium contrast dangerous?

Modern macrocyclic agents carry very low risk in patients with normal or mildly reduced kidney function, and the nephrogenic systemic fibrosis risk associated with older agents is close to zero with current ones. Allergic reactions occur but are rare. Trace gadolinium can deposit in the brain, though no clinical consequences have been demonstrated.

What if my MRI shows scar I didn’t know I had?

That’s common, especially when the scan was ordered for something else. A small subendocardial scar in a coronary distribution suggests a prior silent heart attack and calls for secondary prevention with a statin, blood pressure control, and antiplatelet therapy. Mid-wall scar of unclear cause usually needs more workup.

Will I be able to drive home?

Yes, unless you took oral sedation for claustrophobia. The scan itself causes no drowsiness or weakness. You can drive, go to work, eat and drink, and resume everything normally.

References

1. Kramer, Christopher M., Juerg Barkhausen, Chiara Bucciarelli-Ducci, et al. “Standardized Cardiovascular Magnetic Resonance Imaging (CMR) Protocols: 2020 Update.” Journal of Cardiovascular Magnetic Resonance 22, no. 1 (2020): 17.

2. Friedrich, Matthias G., Udo Sechtem, Jeanette Schulz-Menger, et al. “Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper.” Journal of the American College of Cardiology 53, no. 17 (2009): 1475-1487.

3. Ferreira, Vanessa M., Sven Plein, Tim Wong, et al. “Cardiovascular Magnetic Resonance for Evaluation of Cardiac Involvement in COVID-19-Related Inflammatory and Non-Inflammatory Conditions.” Journal of Cardiovascular Magnetic Resonance 25, no. 1 (2023): 21.

4. Fontana, Marianna, Stefania Rosmini, Daniel S. Knight, et al. “Native T1 Mapping in Cardiac Amyloidosis.” JACC: Cardiovascular Imaging 7, no. 2 (2014): 157-165.

5. Greulich, Simon, Christof Sebastian Deluigi, Stefanie Gloekler, et al. “CMR Imaging Predicts Death and Other Adverse Events in Suspected Cardiac Sarcoidosis.” JACC: Cardiovascular Imaging 6, no. 4 (2013): 501-511.

6. Maron, Martin S., Iacopo Olivotto, Charlene Harrigan, et al. “Mitral Valve Abnormalities Identified by Cardiovascular Magnetic Resonance Represent a Primary Phenotypic Expression of Hypertrophic Cardiomyopathy.” Circulation 124, no. 1 (2011): 40-47.

7. Greenwood, John P., Neil Maredia, John F. Younger, et al. “Cardiovascular Magnetic Resonance and Single-Photon Emission Computed Tomography for Diagnosis of Coronary Heart Disease (CE-MARC): A Prospective Trial.” Lancet 379, no. 9814 (2012): 453-460.

8. Hundley, W. Gregory, David A. Bluemke, J. Paul Finn, et al. “ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance.” Journal of the American College of Cardiology 55, no. 23 (2010): 2614-2662.

9. Wassmuth, Ralf, and Jeanette Schulz-Menger. “Cardiovascular Magnetic Resonance Imaging in Myocardial Disease.” Journal of Cardiovascular Magnetic Resonance 13 (2011): 53.

10. Maceira, Alicia M., Jayshree Joshi, Sanjay K. Prasad, et al. “Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.” Circulation 111, no. 2 (2005): 186-193.

11. Mewton, Nathan, Chia-Ying Liu, Pierre Croisille, David Bluemke, and Joao A. C. Lima. “Assessment of Myocardial Fibrosis with Cardiovascular Magnetic Resonance.” Journal of the American College of Cardiology 57, no. 8 (2011): 891-903.

12. Karamitsos, Theodoros D., Jane M. Francis, Saul Myerson, Joseph B. Selvanayagam, and Stefan Neubauer. “The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure.” Journal of the American College of Cardiology 54, no. 15 (2009): 1407-1424.